Immune Defects in the Risk of Infection and Response to Vaccination in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Overview of attention for article published in Frontiers in immunology, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 1 policy source

twitter: 7 X users

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 81 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 04 Jul 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.